The notion that the β1AR N-terminus functions as a novel molecular determinant of β1AR signaling responses suggests that therapeutic strategies designed to influence β1AR N-terminal cleavage might be exploited for the treatment of heart failure. Here, ADRB1 is linked to heart failure.